Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Pharmaceutical benefits in nursing homes: falling between two stools.

Peiró S.

Farm Hosp. 2019 May 1;43(3):79-81. doi: 10.7399/fh.11247.

2.

Improving the accuracy of medication adherence measures using linked prescription and dispensation data: findings from the ESOSVAL cohort of patients treated with osteoporosis drugs.

García-Sempere A, Hurtado I, Sanfélix-Genovés J, Rodríguez-Bernal C, Peiró S, Sanfélix-Gimeno G.

Curr Med Res Opin. 2019 May 10:1-10. doi: 10.1080/03007995.2019.1601944. [Epub ahead of print]

PMID:
30924690
3.

Energy efficient partition allocation in mixed-criticality systems.

Guasque A, Balbastre P, Crespo A, Peiró S.

PLoS One. 2019 Mar 18;14(3):e0213333. doi: 10.1371/journal.pone.0213333. eCollection 2019.

4.

Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study.

García-Sempere A, Hurtado I, Bejarano-Quisoboni D, Rodríguez-Bernal C, Santa-Ana Y, Peiró S, Sanfélix-Gimeno G.

PLoS One. 2019 Feb 12;14(2):e0211681. doi: 10.1371/journal.pone.0211681. eCollection 2019.

5.

Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis.

Rodríguez-Bernal CL, García-Sempere A, Hurtado I, Santa-Ana Y, Peiró S, Sanfélix-Gimeno G.

BMJ Open. 2018 Dec 19;8(12):e025102. doi: 10.1136/bmjopen-2018-025102.

6.

Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain.

Hurtado-Navarro I, García-Sempere A, Rodríguez-Bernal C, Santa-Ana-Tellez Y, Peiró S, Sanfélix-Gimeno G.

Front Pharmacol. 2018 Dec 3;9:1353. doi: 10.3389/fphar.2018.01353. eCollection 2018.

7.

Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells.

Verde G, De Llobet LI, Wright RHG, Quilez J, Peiró S, Le Dily F, Beato M.

Cancers (Basel). 2018 Oct 5;10(10). pii: E371. doi: 10.3390/cancers10100371.

8.

Rationale and design of a pragmatic clinical trial to assess the impact of self-monitoring blood pressure at home and self-titration of antihypertensive medication in poorly controlled hypertension: the ADAMPA study protocol.

Sanfélix-Genovés J, Rodríguez-Bernal CL, Marco-Moreno I, Martinez-Ibañez P, Martinez-Ibañez L, Bóveda-García M, Barreira-Franch I, Calleja-Del Ser M, Borrás-Moreno G, Avelino-Hidalgo E, Escrig-Veses M, Lauriano M, Giménez-Loreiro M, Bellot-Pujalte L, García-Sempere A, Peiró S, Sanfélix-Gimeno G; ADAMPA group.

BMC Fam Pract. 2018 Sep 24;19(1):160. doi: 10.1186/s12875-018-0846-y.

9.

Lamin B1 mapping reveals the existence of dynamic and functional euchromatin lamin B1 domains.

Pascual-Reguant L, Blanco E, Galan S, Le Dily F, Cuartero Y, Serra-Bardenys G, Di Carlo V, Iturbide A, Cebrià-Costa JP, Nonell L, de Herreros AG, Di Croce L, Marti-Renom MA, Peiró S.

Nat Commun. 2018 Aug 24;9(1):3420. doi: 10.1038/s41467-018-05912-z.

10.

Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain.

Sanfélix-Gimeno G, Juliá-Sanchis ML, Librero J, Peiró S, García-Sempere A.

PLoS One. 2018 Jun 21;13(6):e0199086. doi: 10.1371/journal.pone.0199086. eCollection 2018.

11.

Pinocchio testing in the forensic analysis of waiting lists: using public waiting list data from Finland and Spain for testing Newcomb-Benford's Law.

Pinilla J, López-Valcárcel BG, González-Martel C, Peiro S.

BMJ Open. 2018 May 9;8(5):e022079. doi: 10.1136/bmjopen-2018-022079.

12.

Variation in Antiosteoporotic Drug Prescribing and Spending Across Spain. A Population-Based Ecological Cross-Sectional Study.

Sanfélix-Gimeno G, Librero-López J, Modroño-Riaño G, Peiró S, Rodríguez-Bernal CL.

Front Pharmacol. 2018 Apr 13;9:342. doi: 10.3389/fphar.2018.00342. eCollection 2018.

13.

The effect of telehealth, telephone support or usual care on quality of life, mortality and healthcare utilization in elderly high-risk patients with multiple chronic conditions. A prospective study.

Valdivieso B, García-Sempere A, Sanfélix-Gimeno G, Faubel R, Librero J, Soriano E, Peiró S; GeChronic Group.

Med Clin (Barc). 2018 Oct 23;151(8):308-314. doi: 10.1016/j.medcli.2018.03.013. Epub 2018 Apr 25. English, Spanish.

PMID:
29705155
14.

Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.

Rodriguez-Bernal CL, Peiró S, Hurtado I, García-Sempere A, Sanfélix-Gimeno G.

J Manag Care Spec Pharm. 2018 May;24(5):440-448. doi: 10.18553/jmcp.2018.24.5.440.

15.

Cost-utility analysis on telemonitoring of users with pacemakers: The PONIENTE study.

Lopez-Villegas A, Catalan-Matamoros D, Robles-Musso E, Bautista-Mesa R, Peiro S.

J Telemed Telecare. 2019 May;25(4):204-212. doi: 10.1177/1357633X18767184. Epub 2018 Apr 6.

PMID:
29621908
16.

Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial.

Ferrando C, Soro M, Unzueta C, Suarez-Sipmann F, Canet J, Librero J, Pozo N, Peiró S, Llombart A, León I, India I, Aldecoa C, Díaz-Cambronero O, Pestaña D, Redondo FJ, Garutti I, Balust J, García JI, Ibáñez M, Granell M, Rodríguez A, Gallego L, de la Matta M, Gonzalez R, Brunelli A, García J, Rovira L, Barrios F, Torres V, Hernández S, Gracia E, Giné M, García M, García N, Miguel L, Sánchez S, Piñeiro P, Pujol R, García-Del-Valle S, Valdivia J, Hernández MJ, Padrón O, Colás A, Puig J, Azparren G, Tusman G, Villar J, Belda J; Individualized PeRioperative Open-lung VEntilation (iPROVE) Network.

Lancet Respir Med. 2018 Mar;6(3):193-203. doi: 10.1016/S2213-2600(18)30024-9. Epub 2018 Jan 19.

PMID:
29371130
17.

Snail1 transcription factor controls telomere transcription and integrity.

Mazzolini R, Gonzàlez N, Garcia-Garijo A, Millanes-Romero A, Peiró S, Smith S, García de Herreros A, Canudas S.

Nucleic Acids Res. 2018 Jan 9;46(1):146-158. doi: 10.1093/nar/gkx958.

18.

Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats.

Izquierdo-Bouldstridge A, Bustillos A, Bonet-Costa C, Aribau-Miralbés P, García-Gomis D, Dabad M, Esteve-Codina A, Pascual-Reguant L, Peiró S, Esteller M, Murtha M, Millán-Ariño L, Jordan A.

Nucleic Acids Res. 2017 Nov 16;45(20):11622-11642. doi: 10.1093/nar/gkx746.

19.

Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study.

García-Sempere A, Hurtado I, Sanfélix-Genovés J, Rodríguez-Bernal CL, Gil Orozco R, Peiró S, Sanfélix-Gimeno G.

Sci Rep. 2017 Sep 18;7(1):11784. doi: 10.1038/s41598-017-10899-6.

20.

A Multilevel Analysis of Real-World Variations in Oral Anticoagulation Initiation for Atrial Fibrillation in Valencia, a European Region.

García-Sempere A, Bejarano-Quisoboni D, Librero J, Rodríguez-Bernal CL, Peiró S, Sanfélix-Gimeno G.

Front Pharmacol. 2017 Aug 24;8:576. doi: 10.3389/fphar.2017.00576. eCollection 2017.

21.

Rationale and study design for an individualised perioperative open-lung ventilatory strategy with a high versus conventional inspiratory oxygen fraction (iPROVE-O2) and its effects on surgical site infection: study protocol for a randomised controlled trial.

Ferrando C, Soro M, Unzueta C, Canet J, Tusman G, Suarez-Sipmann F, Librero J, Peiró S, Pozo N, Delgado C, Ibáñez M, Aldecoa C, Garutti I, Pestaña D, Rodríguez A, García Del Valle S, Diaz-Cambronero O, Balust J, Redondo FJ, De La Matta M, Gallego L, Granell M, Martínez P, Pérez A, Leal S, Alday K, García P, Monedero P, Gonzalez R, Mazzinari G, Aguilar G, Villar J, Belda FJ; iPROVE-O2 Network Group.

BMJ Open. 2017 Jul 31;7(7):e016765. doi: 10.1136/bmjopen-2017-016765.

22.

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.

Rodríguez-Bernal CL, Hurtado I, García-Sempere A, Peiró S, Sanfélix-Gimeno G.

Front Pharmacol. 2017 Feb 17;8:63. doi: 10.3389/fphar.2017.00063. eCollection 2017.

23.

Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome.

González López-Valcárcel B, Librero J, García-Sempere A, Peña LM, Bauer S, Puig-Junoy J, Oliva J, Peiró S, Sanfélix-Gimeno G.

Heart. 2017 Jul;103(14):1082-1088. doi: 10.1136/heartjnl-2016-310610. Epub 2017 Mar 1.

24.

Factors associated with hospitalisations in chronic conditions deemed avoidable: ecological study in the Spanish healthcare system.

Angulo-Pueyo E, Ridao-López M, Martínez-Lizaga N, García-Armesto S, Peiró S, Bernal-Delgado E.

BMJ Open. 2017 Feb 24;7(2):e011844. doi: 10.1136/bmjopen-2016-011844. Erratum in: BMJ Open. 2019 Apr 3;9(4):e011844corr1.

25.

Applying spatio-temporal models to assess variations across health care areas and regions: Lessons from the decentralized Spanish National Health System.

Librero J, Ibañez B, Martínez-Lizaga N, Peiró S, Bernal-Delgado E; Spanish Atlas of Medical Practice Variation Research Group.

PLoS One. 2017 Feb 6;12(2):e0170480. doi: 10.1371/journal.pone.0170480. eCollection 2017.

26.

Antibiotic Use in Children - A Cross-National Analysis of 6 Countries.

Youngster I, Avorn J, Belleudi V, Cantarutti A, Díez-Domingo J, Kirchmayer U, Park BJ, Peiró S, Sanfélix-Gimeno G, Schröder H, Schüssel K, Shin JY, Shin SM, Simonsen GS, Blix HS, Tong A, Trifirò G, Ziv-Baran T, Kim SC.

J Pediatr. 2017 Mar;182:239-244.e1. doi: 10.1016/j.jpeds.2016.11.027. Epub 2016 Dec 21.

PMID:
28012694
27.

Lysyl oxidase-like 2 (LOXL2) oxidizes trimethylated lysine 4 in histone H3.

Herranz N, Dave N, Millanes-Romero A, Pascual-Reguant L, Morey L, Díaz VM, Lórenz-Fonfría V, Gutierrez-Gallego R, Jerónimo C, Iturbide A, Di Croce L, García de Herreros A, Peiró S.

FEBS J. 2016 Dec;283(23):4263-4273. doi: 10.1111/febs.13922. Epub 2016 Oct 30.

28.

Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models.

Librero J, Sanfélix-Gimeno G, Peiró S.

PLoS One. 2016 Aug 23;11(8):e0161381. doi: 10.1371/journal.pone.0161381. eCollection 2016.

29.

Trends and area variations in Potentially Preventable Admissions for COPD in Spain (2002-2013): a significant decline and convergence between areas.

Librero J, Ibañez-Beroiz B, Peiró S, Ridao-López M, Rodríguez-Bernal CL, Gómez-Romero FJ, Bernal-Delgado E; Spanish Atlas of Medical Practice Variation Research Group.

BMC Health Serv Res. 2016 Aug 9;16(a):367. doi: 10.1186/s12913-016-1624-y.

30.

Retraction Notice to: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3.

Herranz N, Dave N, Millanes-Romero A, Morey L, Díaz VM, Lórenz-Fonfría V, Gutierrez-Gallego R, Jerónimo C, Di Croce L, García de Herreros A, Peiró S.

Mol Cell. 2016 Jul 7;63(1):180. doi: 10.1016/j.molcel.2016.06.013. No abstract available.

31.

Altered oncomodules underlie chromatin regulatory factors driver mutations.

Frigola J, Iturbide A, Lopez-Bigas N, Peiro S, Gonzalez-Perez A.

Oncotarget. 2016 May 24;7(21):30748-59. doi: 10.18632/oncotarget.8752.

32.

The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review.

Catalá-López F, Ridao M, Alonso-Arroyo A, García-Altés A, Cameron C, González-Bermejo D, Aleixandre-Benavent R, Bernal-Delgado E, Peiró S, Tabarés-Seisdedos R, Hutton B.

Syst Rev. 2016 Jan 7;5:6. doi: 10.1186/s13643-015-0181-5. Review.

33.

Effectiveness of pacemaker tele-monitoring on quality of life, functional capacity, event detection and workload: The PONIENTE trial.

Lopez-Villegas A, Catalan-Matamoros D, Robles-Musso E, Peiro S.

Geriatr Gerontol Int. 2016 Nov;16(11):1188-1195. doi: 10.1111/ggi.12612. Epub 2015 Dec 4.

PMID:
26635263
34.

Primary Non-Adherence to Antiosteoporotic Treatment and Associated Factors: A Prospective Cohort Study in Spain.

Hurtado I, Sanfélix-Gimeno G, Peiró S, Sanfélix-Genovés J.

Value Health. 2015 Nov;18(7):A650. doi: 10.1016/j.jval.2015.09.2337. Epub 2015 Oct 20. No abstract available.

35.

Effectiveness and Safety of New and Traditional Oral Anticoagulants in a Population-Based Cohort of New Users with Atrial Fibrillation.

Sanfélix-Gimeno G, Rodríguez-Bernal C, Hurtado I, Librero J, Baixauli C, Peiró S.

Value Health. 2015 Nov;18(7):A378. doi: 10.1016/j.jval.2015.09.793. Epub 2015 Oct 20. No abstract available.

36.

Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol.

Sanfélix-Gimeno G, Rodríguez-Bernal CL, Hurtado I, Baixáuli-Pérez C, Librero J, Peiró S.

BMJ Open. 2015 Oct 19;5(10):e007613. doi: 10.1136/bmjopen-2015-007613.

37.

Workload, time and costs of the informal cares in patients with tele-monitoring of pacemakers: the PONIENTE study.

López-Villegas A, Catalán-Matamoros D, Robles-Musso E, Peiró S.

Clin Res Cardiol. 2016 Apr;105(4):307-13. doi: 10.1007/s00392-015-0921-5. Epub 2015 Sep 30.

PMID:
26423396
38.

Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain.

Sanfélix-Gimeno G, Hurtado I, Sanfélix-Genovés J, Baixauli-Pérez C, Rodríguez-Bernal CL, Peiró S.

PLoS One. 2015 Aug 28;10(8):e0135475. doi: 10.1371/journal.pone.0135475. eCollection 2015.

39.

[Comparative Effectiveness of Remote Monitoring of People with Cardiac Pacemaker versus Conventional: quality of Life at the 6 Months].

López-Villegas A, Catalán-Matamoros D, Robles-Musso E, Peiró S.

Rev Esp Salud Publica. 2015 Apr;89(2):149-58. doi: 10.4321/S1135-57272015000200004. Spanish.

40.

Splicing of a non-coding antisense transcript controls LEF1 gene expression.

Beltran M, Aparicio-Prat E, Mazzolini R, Millanes-Romero A, Massó P, Jenner RG, Díaz VM, Peiró S, de Herreros AG.

Nucleic Acids Res. 2015 Jul 13;43(12):5785-97. doi: 10.1093/nar/gkv502. Epub 2015 May 18.

41.

LOXL2 Oxidizes Methylated TAF10 and Controls TFIID-Dependent Genes during Neural Progenitor Differentiation.

Iturbide A, Pascual-Reguant L, Fargas L, Cebrià JP, Alsina B, García de Herreros A, Peiró S.

Mol Cell. 2015 Jun 4;58(5):755-66. doi: 10.1016/j.molcel.2015.04.012. Epub 2015 May 7.

42.

Rationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): study protocol for a randomized controlled trial.

Ferrando C, Soro M, Canet J, Unzueta MC, Suárez F, Librero J, Peiró S, Llombart A, Delgado C, León I, Rovira L, Ramasco F, Granell M, Aldecoa C, Diaz O, Balust J, Garutti I, de la Matta M, Pensado A, Gonzalez R, Durán ME, Gallego L, Del Valle SG, Redondo FJ, Diaz P, Pestaña D, Rodríguez A, Aguirre J, García JM, García J, Espinosa E, Charco P, Navarro J, Rodríguez C, Tusman G, Belda FJ; iPROVE investigators (Appendices 1 and 2).

Trials. 2015 Apr 27;16:193. doi: 10.1186/s13063-015-0694-1.

43.

[Children's relative age in class and medication for attention-deficit/hyperactivity disorder. A population-based study in a health department in Spain].

Librero J, Izquierdo-María R, García-Gil M, Peiró S.

Med Clin (Barc). 2015 Dec 7;145(11):471-6. doi: 10.1016/j.medcli.2015.02.022. Epub 2015 Apr 23. Spanish.

PMID:
25913908
44.

Variations in health care delivery within the European Union.

Peiró S, Maynard A.

Eur J Public Health. 2015 Feb;25 Suppl 1:1-2. doi: 10.1093/eurpub/cku223. No abstract available.

PMID:
25690122
45.

Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.

Kim SC, Kim MS, Sanfélix-Gimeno G, Song HJ, Liu J, Hurtado I, Peiró S, Lee J, Choi NK, Park BJ, Avorn J.

Am J Med. 2015 May;128(5):519-26.e1. doi: 10.1016/j.amjmed.2015.01.014. Epub 2015 Feb 3.

46.

[In healthcare, more or less, less is more: notes on healthcare disinvestment].

Peiró S.

Rev Esp Sanid Penit. 2014;16(3):68-74. doi: 10.4321/S1575-06202014000300002. Spanish.

47.

A new role for LOX and LOXL2 proteins in transcription regulation.

Iturbide A, García de Herreros A, Peiró S.

FEBS J. 2015 May;282(9):1768-73. doi: 10.1111/febs.12961. Epub 2014 Sep 6. Review.

48.

[C-section rate in low-risk women: a useful indicator to compare hospitals attending deliveries with different risks].

Librero J, Peiró S, Belda A, Calabuig J.

Rev Esp Salud Publica. 2014 May-Jun;88(3):315-26. doi: 10.4321/S1135-57272014000300002. Spanish.

49.

[Barriers for introducing a health technology assessment organization to inform health care decision-making in the Spanish National Health System].

Artells JJ, Peiró S, Meneu R.

Rev Esp Salud Publica. 2014 Mar-Apr;88(2):217-31. doi: 10.4321/S1135-57272014000200005. Spanish.

50.

[Declaration of transparency: promoting a more complete, honest and adequate publication of scientific articles].

Catalá-López F, Peiró S, Hutton B, Pérez Andrés C, Moher D.

Rev Esp Salud Publica. 2014 Mar-Apr;88(2):181-6. doi: 10.4321/S1135-57272014000200001. English, Spanish. No abstract available.

Supplemental Content

Support Center